Sep 2, 2015 ... limited to one such submission for all plaintiffs and one such ..... ARMSTRONG, ET AL. v. .... Pharmaceuticals, Inc., Janssen Research & Development, LLC, ... Meunier and Leonard A. Davis are well qualified to carry out the ...


Olson et al v. Janssen Research & Development LLC et al Court: Louisiana Eastern District Court Case Num: 2:19-cv-00283. Filed: Jan 15, 2019. Nature of suit: ...


Oct 12, 2016 ... ... Allen v. Janssen Pharmaceuticals, Inc., et al., Case No. 3:15- ... Janssen Research & Development LLC, No. ..... 1:16-cv-08838: Joy Davis vs.


JANSSEN PHARMACEUTICALS INC JOHNSON JOHNSON JANSSEN RESEARCH ... and Janssen Research & Development, LLC, have taken cross- appeals from the judgment entered in ... All of the cases in this mass tort involve male plaintiffs who allege they developed ..... Parke, Davis & Co., 679 N.W.2d 867, 876 (Wis.


Dec 21, 2017 ... CAR-T BCMA in Development for Patients with Multiple Myeloma. ... M.D., Ph.D., Global Therapeutic Area Head, Oncology, Janssen Research & Development, LLC. ... [1],[2]While some patients with myeloma have no symptoms at all, most patients are diagnosed due to ... Linda Davis ... [1] Kumar, SK et al.


Explore Janssen's innovative medical research and development practices, and see how Janssen is dedicated to the well-being of patients around the world.


Dec 7, 2016 ... Invokana and its sister drug Invokamet belong to a class of. 2 diabetes drugs .... DAVIS v. JANSSEN PHARMACEUTICALS, INC., C.A. No. 1:16-08838 ... JANSSEN RESEARCH & DEVELOPMENT LLC, ET AL., C.A. No. 3:16- ...


... of America et al v. Janssen Pharmaceutical N.V. et al, case number 2:16-cv- 06997, from California Central Court. ... Janssen Research and Development, LLC ...


Feb 3, 2018 ... Open AccessPharmacokinetics and Exposure Response ...... and Hugh M. Davis are employees of Janssen Research & Development, LLC.